TEHRAN: Iran began its vaccination campaign against COVID-19 on Tuesday (Feb 9) to fight the Middle East's deadliest outbreak of the illness, images broadcast by state television showed.
"We begin our national vaccination against the COVID-19 virus ... (in) memory of the martyrdom of health workers," Iran's President Hassan Rouhani said at a ceremony at a Tehran hospital, referring to medical personnel who have died from the disease.
Iran's inoculation effort for its 80 million-plus population is starting with Russia's Sputnik V vaccine, authorities have said.
The first doses of the Russian vaccine arrived in Tehran on Thursday, with two more shipments expected by Feb 18 and 28, according to Iranian authorities.
The Islamic republic has bought two million doses of Sputnik V, health ministry spokesman Kianoush Jahanpour told AFP on Saturday.
Health Minister Saeed Namaki said last week that Iran would also receive 4.2 million doses of the vaccine developed by Anglo-Swedish firm AstraZeneca and Oxford University, purchased via the international vaccine mechanism COVAX.
COVID-19 has infected 1.4 million people in Iran and killed more than 58,500, according to the health ministry.
The country started clinical trials of its own first locally developed vaccine in late December and on Monday unveiled a second homegrown vaccine project.
The second Iranian vaccine, dubbed Razi Cov Pars, was developed at the Razi Vaccine and Serum Research Institute, which is linked to the agriculture ministry, according to Massoud Soleimani, a member of Iran's national vaccine committee.